【结 构 式】 |
【药物名称】VRC-3807 【化学名称】N-[3-[3-Fluoro-4-[N-methyl-N-(thioformyl)amino]phenyl]-2-oxooxazolidin-5(S)-ylmethyl]thioacetamide 【CA登记号】324788-67-2 【 分 子 式 】C14H16FN3O2S2 【 分 子 量 】341.42892 |
【开发单位】Pfizer (Originator), Vicuron Pharmaceuticals (Originator) 【药理作用】Antibacterial Drugs, ANTIINFECTIVE THERAPY, Oxazolidinones |
合成路线1
Jones oxidation of 2-fluoro-4-nitrotoluene (I) afforded carboxylic acid (II). After activation of (II) as the corresponding acid chloride with SOCl2, reaction with lithium tert-butoxide furnished the tert-butyl ester (III). Reduction of the nitro group of (III) by means of iron powder in the presence of ammonium chloride gave amine (IV), which was converted to carbamate (V) upon treatment with benzyl chloroformate. The chiral oxazolidinone (VII) was prepared by condensation of the lithium salt of carbamate (V) with (R)-glycidyl butyrate (VI). After activation of the primary hydroxyl of (VII) as the corresponding mesylate, displacement with NaN3 in hot DMF provided the alkyl azide (VIII). Tert-Butyl ester cleavage in (VIII) by means of trifluoroacetic acid afforded the carboxylic acid (IX). Curtius rearrangement of acid (IX) with diphenylphosphoryl azide in the presence of tert-butanol generated the tert-butyl carbamate (X). Further N-alkylation of carbamate (X) using iodomethane and LiH gave the N-methyl analogue (XI). Then, reduction of the azido group of (XI) to the primary amine (XII) was accomplished by treatment with triphenylphosphine followed by aqueous hydrolysis.
【1】 Singh, U.; Gordeev, M.F.; Luehr, G.W.; Gadwood, R.C.; Jain, R.; Hackbarth, C.J.; Trias, J.; Patel, D.V.; Lopez, S.; Acyclic C-group oxazolidinones: Antimicrobial 4'-acylamino, 4'-urea and 4'-thiourea phenyloxazolidinones. 41st Intersci Conf Antimicrob Agents Chemother (Dec 16 2001, Chicago) 2001, Abst F-1045. |
【2】 Patel, D.V.; Gadwood, R.C.; Gordeev, M.F.; Luehr, G.W. (Pharmacia Corp.); Oxazolidinones and their use as antiinfectives. EP 1200416; US 6441005; WO 0109107 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 55902 | 2-Fluoro-4-nitrotoluene; 4-Nitro-2-fluorotoluene | 1427-07-2 | C7H6FNO2 | 详情 | 详情 |
(II) | 55903 | 2-Fluoro-4-nitrobenzoic acid | 403-24-7 | C7H4FNO4 | 详情 | 详情 |
(III) | 55904 | tert-butyl 2-fluoro-4-nitrobenzoate | C11H12FNO4 | 详情 | 详情 | |
(IV) | 55905 | tert-butyl 4-amino-2-fluorobenzoate | C11H14FNO2 | 详情 | 详情 | |
(V) | 55906 | tert-butyl 4-{[(benzyloxy)carbonyl]amino}-2-fluorobenzoate | C19H20FNO4 | 详情 | 详情 | |
(VI) | 18385 | (2R)oxiranylmethyl butyrate;(R)-glycidyl butyrate | 60456-26-0 | C7H12O3 | 详情 | 详情 |
(VII) | 55907 | tert-butyl 2-fluoro-4-[(5R)-5-(hydroxymethyl)-2-oxo-1,3-oxazolidin-3-yl]benzoate | C15H18FNO5 | 详情 | 详情 | |
(VIII) | 55908 | tert-butyl 4-[(5R)-5-(azidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorobenzoate | C15H17FN4O4 | 详情 | 详情 | |
(IX) | 55909 | 4-[(5R)-5-(azidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorobenzoic acid | C11H9FN4O4 | 详情 | 详情 | |
(X) | 58661 | tert-butyl 4-[(5R)-5-(azidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenylcarbamate | C15H18FN5O4 | 详情 | 详情 | |
(XI) | 58662 | tert-butyl 4-[(5R)-5-(azidomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl(methyl)carbamate | C16H20FN5O4 | 详情 | 详情 | |
(XII) | 58663 | tert-butyl 4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl(methyl)carbamate | C16H22FN3O4 | 详情 | 详情 |
合成路线2
Amine (XII) was acylated by acetic anhydride in pyridine to afford acetamide (XIII). The N-Boc protecting group of (XIII) was then removed under acidic conditions to give amine (XIV), which was converted into formamide (XV) by treatment with p-nitrophenyl formate. Finally, thionation of both amide groups of (XV) by means of Lawesson's reagent in hot dioxane provided the target bis-thioamide.
【1】 Singh, U.; Gordeev, M.F.; Luehr, G.W.; Gadwood, R.C.; Jain, R.; Hackbarth, C.J.; Trias, J.; Patel, D.V.; Lopez, S.; Acyclic C-group oxazolidinones: Antimicrobial 4'-acylamino, 4'-urea and 4'-thiourea phenyloxazolidinones. 41st Intersci Conf Antimicrob Agents Chemother (Dec 16 2001, Chicago) 2001, Abst F-1045. |
【2】 Patel, D.V.; Gadwood, R.C.; Gordeev, M.F.; Luehr, G.W. (Pharmacia Corp.); Oxazolidinones and their use as antiinfectives. EP 1200416; US 6441005; WO 0109107 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XII) | 58663 | tert-butyl 4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]-2-fluorophenyl(methyl)carbamate | C16H22FN3O4 | 详情 | 详情 | |
(XIII) | 58664 | tert-butyl 4-{(5S)-5-[(acetylamino)methyl]-2-oxo-1,3-oxazolidin-3-yl}-2-fluorophenyl(methyl)carbamate | C18H24FN3O5 | 详情 | 详情 | |
(XIV) | 58665 | N-({(5S)-3-[3-fluoro-4-(methylamino)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide | C13H16FN3O3 | 详情 | 详情 | |
(XV) | 58666 | N-[((5S)-3-{3-fluoro-4-[formyl(methyl)amino]phenyl}-2-oxo-1,3-oxazolidin-5-yl)methyl]acetamide | C14H16FN3O4 | 详情 | 详情 |